How should security teams evaluate SaaS app risk when GenAI features may expose company data?

Why SaaS Apps with GenAI Features Change the Review Standard

Once a SaaS product can route customer prompts, documents, or metadata into GenAI workflows, the review is no longer just about classic vendor access and privacy disclosures. Security teams need to understand where the data goes, whether it is retained, whether it is used to improve models, and whether the application introduces a new processing boundary outside the original SaaS service. That matters because the same user action can now create a broader disclosure path than the core product description suggests.

The key issue is not whether GenAI is present in abstract terms, but whether it materially changes the handling of company data. A product may still be legitimate and useful while creating a higher-risk trust boundary, especially if the provider uses external AI services, combines customer content with third-party processing, or gives employees a simple way to submit sensitive material without strong guardrails. In practice, many security teams discover this change only after users have already adopted the feature for everyday work, rather than through intentional review.

For broader AI and cyber governance context, NIST’s NIST Cybersecurity Framework 2.0 remains useful for structuring the control conversation around governance, protection, detection, and recovery.

How Security Teams Should Evaluate the Data Path

A useful evaluation starts with the data path, not the marketing label. Security teams should identify what the SaaS app can ingest, what the GenAI feature can generate, where prompts or attachments are processed, and whether any of that content leaves the supplier’s primary environment. If the application forwards data to a third-party model provider, the risk profile changes again because the organisation has added another processor, another policy set, and another set of retention and logging assumptions.

The practical review should include four questions. First, does the app state whether customer data is excluded from model training, and is that statement contractually backed by the vendor? Second, does the feature allow users to submit regulated, confidential, or highly sensitive data that would normally be restricted elsewhere? Third, can administrators disable the GenAI feature, limit it to approved groups, or block specific content classes? Fourth, can the organisation trace which users interacted with the feature and what categories of data were exposed?

• Map the exact prompts, files, and metadata the feature can process.
• Check whether third-party AI services receive customer content or derived content.
• Review retention, deletion, logging, and opt-out terms for model training.
• Confirm whether access controls, DLP, and admin settings can constrain use.

That review should also distinguish between a feature that summarises already approved content and a feature that can ingest broad, user-selected material from internal systems. The latter creates more exposure because employees often treat a convenience feature as if it were an approved data-handling channel. Where the vendor documentation is vague, security teams should treat the absence of a clear processing statement as a risk signal, not as a neutral gap. The guidance breaks down when the provider will not disclose downstream AI processors or when the organisation cannot verify what data categories the feature actually receives.

Where the Risk Becomes Material and What Controls Usually Get Missed

Tighter GenAI enablement often increases adoption speed, but it also raises the chance that users will paste in information they would never place into a normal support chat or public web tool. That tradeoff matters because the control failure is usually behavioural as much as technical: the app may be legitimate, yet the organisation has no effective boundary around what employees can disclose through it.

There is also a common edge case around “private” AI features embedded inside otherwise familiar business software. Teams often assume those features inherit the parent vendor’s security posture, but the actual processing model may be different. Some features use separate AI subprocessors, separate retention logic, or separate policy exceptions that do not appear in the main product overview. The safest review stance is to treat each GenAI-capable feature as its own data-processing path unless the vendor proves otherwise.

Another important variation is governance ambiguity. If procurement, privacy, and security each review the SaaS application separately, the GenAI feature can slip between ownership boundaries. That is where assessment becomes inconsistent: the app may pass vendor due diligence, but the feature still creates an unreviewed path for sensitive company data. The practical standard should be simple: if the feature changes where data is processed, retained, or trained on, it deserves a fresh review. For AI-specific governance context, the NIST AI 600-1 GenAI Profile is useful when teams need a structured way to think about generative AI risk boundaries and controls.

Risk and Threat Considerations

GenAI-enabled SaaS can create a material data exposure risk when user content is routed to external processors, retained longer than expected, or reused in ways the organisation did not intend. The main risk is not only accidental disclosure, but also loss of control over the trust boundary that separates approved business processing from downstream model services.

Failure mechanism: Users submit sensitive content into a feature that looks native to the SaaS app, but the app forwards that content to a third-party GenAI service or stores it for model improvement, logging, or quality review. If the vendor’s disclosures are incomplete or the organisation has no feature-level controls, sensitive data can move outside the original access and retention model without a clear administrative decision.

Impact: Company data may be exposed to additional processors, retained in unexpected systems, or made available to broader internal or external support paths. That can increase privacy, contractual, and compliance risk, while also weakening the organisation’s ability to explain where sensitive information went and who can access it.

Practitioner Guidance

What to prioritise: Classify the GenAI feature as a distinct data path, not a minor product enhancement. If the feature can process regulated, confidential, or high-value internal content, require a higher review bar than for ordinary SaaS functionality.

What to verify: Confirm whether the vendor uses customer data for training, whether third-party model providers receive prompts or attachments, and whether admins can disable or scope the feature. Also verify that the vendor’s written terms match the product’s actual behaviour, not just the sales description.

Common mistake: Treating a familiar SaaS brand as evidence of safe AI handling. Security teams often over-trust the parent application and under-review the embedded AI path, especially when the feature is bundled into existing licensing or user workflows.

Practitioner takeaway: The decisive question is not whether the SaaS app is acceptable in general, but whether its GenAI feature creates a new disclosure and retention boundary that the organisation can actually govern.

Related resources from NHI Mgmt Group

• How should security teams evaluate third-party SaaS app risk in identity governance programs?
• How should security teams control SaaS data sharing risk?
• Why do GenAI chat tools create data leakage risk for IAM and security teams?
• How should security teams evaluate a data security platform against identity risk?